» Articles » PMID: 37577745

Oxidized Low-density Lipoproteins and Lipopolysaccharides Augment Carotid Artery Plaque Vulnerability in Hypercholesterolemic Microswine

Overview
Publisher Fortune Journals
Date 2023 Aug 14
PMID 37577745
Authors
Affiliations
Soon will be listed here.
Abstract

Atherosclerosis is a chronic inflammatory disease and hypercholesterolemia is a risk factor. This study aims to compare the potency of lipopolysaccharide (LPS) and oxidized low-density lipoproteins (oxLDL) to induce plaque formation and increase plaque vulnerability in the carotid artery of hypercholesterolemic Yucatan microswine. Atherosclerotic lesions at the common carotid artery junction and ascending pharyngeal artery were induced in hypercholesterolemic Yucatan microswine at 5-6 months of age with balloon angioplasty. LPS or oxLDL were administered intraluminally at the site of injury after occluding the arterial flow temporarily. Pre-intervention ultrasound (US), angiography, and optical coherence tomography (OCT) were done at baseline and just before euthanasia to assess post-op parameters. The images from the US, OCT, and angiography in the LPS and the oxLDL-treated group showed increased plaque formation with features suggestive of unstable plaque, including necrotic core, thin fibrous caps, and a signal poor region more with oxLDL compared to LPS. Histomorphology of the carotid artery tissue near the injury corroborated the presence of severe lesions in both LPS and oxLDL-treated pigs but more in the oxLDL group. Vascular smooth muscle and endothelial cells treated with LPS and oxLDL showed increased folds changes in mRNA transcripts of the biomarkers of inflammation and plaque vulnerability compared to untreated cells. Collectively, the results suggest that angioplasty-mediated intimal injury of the carotid arteries in atherosclerotic swine with local administration of LPS or ox-LDL induces vulnerable plaques compared to angioplasty alone and oxLDL is relatively more potent than LPS in inducing vulnerable plaque.

Citing Articles

High-Fat Diet, Epigenetics, and Atherosclerosis: A Narrative Review.

Rai V Nutrients. 2025; 17(1.

PMID: 39796562 PMC: 11722563. DOI: 10.3390/nu17010127.


Inflammation and Fatty Infiltration Correlates with Rotator Cuff Muscle Atrophy in Hypercholesterolemic Yucatan Microswine.

Le H, Rai V, Agrawal D J Orthop Sports Med. 2024; 6(3):198-213.

PMID: 39639857 PMC: 11619632. DOI: 10.26502/josm.511500161.


Targeting Oncostatin M Receptor to Attenuate Carotid Artery Plaque Vulnerability in Hypercholesterolemic Microswine.

Trinh J, Shin J, Rai V, Agrawal D Cardiol Cardiovasc Med. 2024; 8(3):206-214.

PMID: 38817407 PMC: 11138392. DOI: 10.26502/fccm.92920380.


Therapeutic Potential of Targeting p27 in Plaque Vulnerability.

Trinh J, Shin J, Rai V, Agrawal D Arch Intern Med Res. 2024; 7(2):73-79.

PMID: 38737892 PMC: 11087066. DOI: 10.26502/aimr.0167.


Research development on gut microbiota and vulnerable atherosclerotic plaque.

Zheng S, Liu Z, Liu H, Lim J, Li D, Zhang S Heliyon. 2024; 10(4):e25186.

PMID: 38384514 PMC: 10878880. DOI: 10.1016/j.heliyon.2024.e25186.


References
1.
Rao V, Rai V, Stoupa S, Subramanian S, Agrawal D . Tumor necrosis factor-α regulates triggering receptor expressed on myeloid cells-1-dependent matrix metalloproteinases in the carotid plaques of symptomatic patients with carotid stenosis. Atherosclerosis. 2016; 248:160-9. PMC: 4836960. DOI: 10.1016/j.atherosclerosis.2016.03.021. View

2.
Abbas A, Gregersen I, Holm S, Daissormont I, Bjerkeli V, Krohg-Sorensen K . Interleukin 23 levels are increased in carotid atherosclerosis: possible role for the interleukin 23/interleukin 17 axis. Stroke. 2015; 46(3):793-9. DOI: 10.1161/STROKEAHA.114.006516. View

3.
Bowman J, Surani S, Horseman M . Endotoxin, Toll-like Receptor-4, and Atherosclerotic Heart Disease. Curr Cardiol Rev. 2016; 13(2):86-93. PMC: 5452150. DOI: 10.2174/1573403X12666160901145313. View

4.
Carroll J, Carter D, Korte S, Prather R . Evaluation of the acute phase response in cloned pigs following a lipopolysaccharide challenge. Domest Anim Endocrinol. 2005; 29(3):564-72. DOI: 10.1016/j.domaniend.2005.03.009. View

5.
Kouassi K, Gunasekar P, Agrawal D, Jadhav G . TREM-1; Is It a Pivotal Target for Cardiovascular Diseases?. J Cardiovasc Dev Dis. 2018; 5(3). PMC: 6162371. DOI: 10.3390/jcdd5030045. View